BI-2493   Click here for help

GtoPdb Ligand ID: 12764

Synonyms: BI2493
PDB Ligand
Compound class: Synthetic organic
Comment: BI-2493 is a non-covalent, pan-KRAS inhibitor that was developed for in vivo studies of anti-tumour potential [1]. It interacts with inactive KRAS and does not disrupt NRAS and HRAS activities. BI-2493 is available through Boehringer Ingelheim's open innovation portal opnMe.com BI-2493.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 2
Topological polar surface area 136.69
Molecular weight 461.58
XLogP 1.24
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@H]1CNCCN1C2=NC(=CC=N2)C3=NOC4=C3CCC[C@]54CCCC6=C5C(=C(N)S6)C#N
Isomeric SMILES C[C@H]1CNCCN1C2=NC=CC(=N2)C3=NOC4=C3CCC[C@@]45CCCC6=C5C(C#N)=C(N)S6
InChI InChI=1S/C24H27N7OS/c1-14-13-27-10-11-31(14)23-28-9-6-17(29-23)20-15-4-2-7-24(21(15)32-30-20)8-3-5-18-19(24)16(12-25)22(26)33-18/h6,9,14,27H,2-5,7-8,10-11,13,26H2,1H3/t14-,24-/m0/s1
InChI Key PVOYBVVIBNPTPJ-BSEYFRJRSA-N
Bioactivity Comments
Treatment with BI-2493 suppresses tumour growth in mice, across a range of tumours with oncogenic KRAS mutations (G12C, G12D, G12V and A146V) and wild type KRAS [1]. Its PK profile supports oral bioavailability.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
KRAS Hs Inhibitor Inhibition ~8.0 pKd - 1
pKd ~8.0 (Kd ~1x10-8 M) [1]
Description: Binding affinity for WT hKRAS